4.7 Article

Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease

Journal

EUROPEAN JOURNAL OF NEUROLOGY
Volume 22, Issue 1, Pages 207-210

Publisher

WILEY-BLACKWELL
DOI: 10.1111/ene.12396

Keywords

deep brain stimulation; odor identification; Parkinson's disease

Funding

  1. EFNS fellowship
  2. Reta Lila Weston Trust for Medical Research
  3. Parkinson's UK
  4. Parkinson's Foundation
  5. Teva Lundbeck
  6. UCB
  7. Genus
  8. Abbott
  9. FAPESP
  10. UNICAMP
  11. GlaxoSmithKline
  12. Grunenthal
  13. Fundacao MSD (Portugal)
  14. TEVA
  15. European Huntington Disease Network
  16. Merck-Serono
  17. Lundbeck
  18. Novartis
  19. Merz
  20. Ipsen
  21. Solvay
  22. BIAL

Ask authors/readers for more resources

Background and purpose: Olfactory dysfunction is common in Parkinson's disease (PD) and it is one of the earliest non-motor symptoms. A few studies have suggested that deep brain stimulation of the subthalamic nucleus (STN-DBS) could improve olfactory function. Our aim was to evaluate the acute effect of bilateral STN-DBS on a commonly used smell test in PD patients. Methods: Fifteen PD patients who underwent bilateral STN-DBS and 15 controls were recruited. Patients and controls were tested for odor identification. Results: No statistical differences were documented between ON and OFF STN-DBS acute stimulation concerning olfaction. Controls presented a better performance for olfactory identification than patients. Conclusions: Our exploratory study did not support that bilateral STN-DBS could have an acute effect on olfactory function in PD patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available